Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus

Clinical trial NCT00290927 · COMPLETED

Trial details

NCT number: NCT00290927
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2003-12-01
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.